NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/07/2025
Voltar para busca
Dado oficial do USPTO
LIMULUS BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LIMULUS BIO
ST13
US500000079319782Classe
35, 41, 42, 45
Pedido
79319782
Registro
6784221
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
18/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 45
Data de depósito
22/01/2021
Data de registro
12/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/07/2022
Última transação
18/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
64
Localização do titular
SE
Examinador
LOBO, DEBORAH
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Limulus Bio AB
Representantes
John Alumit ALUMIT IP
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Data management services in the field of biocompatibilitytoxicologymedical engineeringpharmacologychemical characterisation and development of medical equipment and devices; computerised database management and data processing in the field of medical engineering and devices
Classe 41
Education servicesteaching and training in the fields of medical equipment and devicesbiocompatibility and toxicology; education servicesteaching and training relating to biocompatibilitytoxicologypharmacology and chemical characterization in the fields of medical equipment; publication of medical technical texts and approval documentation in the fields of medical engineering; publication of statistical and clinical reports in the fields of medical engineeringpharmacology and devicesbiocompatibility and toxicology
Classe 42
Conducting of scientific biocompatibility studies and research in the fields of biocompatibilitytoxicologypharmacology and chemical characterization; research and testing in the fields of biocompatibilitytoxicologypharmacology and chemical characterization; consultancy relating to product development in the fields of medical equipment and devicesbiocompatibility and toxicology; scientific servicesconducting of clinical studies and research in the fields of medical equipment and devicesbiocompatibility and toxicology
Classe 45
Consultancy relating to regulatory compliance and validation procedures for assuring regulatory compliance relating to biocompatibilitytoxicologymedical engineering pharmacology and chemical characterization; providing information in the field of regulation about examination and approval processes of regulatory bodies and authorities and registered bodies in the fields of biocompatibilitytoxicologymedical engineeringpharmacology and chemical characterization
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/11/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/10/2022
FIMP
FINAL DISPOSITION PROCESSED
21/10/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/04/2022
PUBO
PUBLISHED FOR OPPOSITION
26/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/04/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/02/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/02/2022
RFNT
REFUSAL PROCESSED BY IB
30/10/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/10/2021
RFRR
REFUSAL PROCESSED BY MPU
01/10/2021
MAFR
APPLICATION FILING RECEIPT MAILED
17/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/09/2021
CNRT
NON-FINAL ACTION WRITTEN
15/09/2021
DOCK
ASSIGNED TO EXAMINER
13/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/09/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIMULUS BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.